Ikarian-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
141
Total Value
710178588
Accession Number
0001420506-25-001276
Form Type
13F-HR
Manager Name
Ikarian-Capital
Data Enrichment
96% identified
135 identified6 unidentified

Holdings

141 positions
Manager:
Search and click to pin securities to the top
Page 6 of 8
Lyell Immunopharma, Inc.
Shares:876.0K
Value:$471.3K
iTeos Therapeutics, Inc.
Shares:78.6K
Value:$469.2K
Vigil Neuroscience, Inc.
Shares:250.0K
Value:$445.0K
AETHLON MEDICAL INC
Shares:1.2M
Value:$440.1K
Alto Neuroscience, Inc.
Shares:175.0K
Value:$378.0K
Mind Medicine (MindMed) Inc.
Shares:62.7K
Value:$366.7K
Third Harmonic Bio, Inc.
Shares:100.0K
Value:$347.0K
Ginkgo Bioworks Holdings, Inc.
Shares:58.3K
Value:$332.3K
Tyra Biosciences, Inc.
Shares:35.0K
Value:$325.5K
Celldex Therapeutics, Inc.
Shares:17.8K
Value:$323.1K
Acumen Pharmaceuticals, Inc.
Shares:265.8K
Value:$292.3K
Cartesian Therapeutics, Inc.
Shares:22.2K
Value:$292.1K
SPRUCE BIOSCIENCES, INC.
Shares:1.0M
Value:$290.1K
Allakos Inc.
Shares:1.2M
Value:$266.7K
GERON CORP
Shares:150.0K
Value:$238.5K
16385C104
Shares:213.1K
Value:$232.2K
Aclaris Therapeutics, Inc.
Shares:150.9K
Value:$230.9K
Monopar Therapeutics
Shares:5.9K
Value:$215.1K
28658R106
Shares:175.1K
Value:$213.6K
PepGen Inc.
Shares:150.0K
Value:$210.8K